CARU - Overview: Cyclic Adenosine Monophosphate (cAMP), Urinary Excretion, Serum and Urine

Differential diagnosis of hypercalcemia As an adjunct to serum parathyroid hormone measurements, especially in the diagnosis of parathyroid hormone resistance states, such as pseudohypoparathyroidism

CA - Overview: Calcium, Total, Serum

Diagnosis and monitoring of a wide range of disorders including diseases of bone, kidney, parathyroid gland, or gastrointestinal tract

HQ - Overview: HemoQuant, Feces

Detection of blood in feces Evaluation of iron deficiency Detection of bleeding as a complication of anticoagulant therapy and other medication regimens This test is not specific for bowel cancer.

FENTS - Overview: Fentanyl, Serum

Monitoring fentanyl therapy

FLUOX - Overview: Fluoxetine, Serum

Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance

IRON - Overview: Iron, Serum

Aiding in the evaluation of iron deficiency and iron overload diseases in combination with total iron binding capacity and percent saturation Assessment of acute iron poisoning

OXCO1 - Overview: Oxalate, Random, Urine

Monitoring therapy for kidney stones Identifying increased urinary oxalate as a risk factor for stone formation Diagnosis of primary or secondary hyperoxaluria

NITF - Overview: Nitrogen, Total, Feces

Determining nitrogen balance, when used in conjunction with 24-hour urine nitrogen measurement Assessing nutritional status (protein malnutrition) Evaluating protein catabolism

PCPMC - Overview: Phencyclidine (PCP) Confirmation, Meconium

Detection of in utero to phencyclidine (PCP) exposure up to 5 months before birth

IDHT - Overview: IDH1 and IDH2 Mutation Analyses, Next-Generation Sequencing, Tumor

Identifying specific mutations within the IDH1 and IDH2 genes that assist in tumor diagnosis/classification and predict response to targeted therapy